Duration of short-acting granulocyte colony-stimulating factor for primary prophylaxis and risk of neutropenia-related hospitalization in older patients with cancer-Reference-Cited by-同舟云学术

Duration of short-acting granulocyte colony-stimulating factor for primary prophylaxis and risk of neutropenia-related hospitalization in older patients with cancer

Published:2020-11 Issue:8 Volume:11 Page:1309-1315
ISSN:1879-4068
Container-title:Journal of Geriatric Oncology
language:en
Short-container-title:Journal of Geriatric Oncology

Author:

Li Shuling,Liu Jiannong,Gong Tingting,Guo Haifeng,Gawade Prasad L.,Kelsh Michael A.,Bradbury Brian D.,Belani Rajesh,Lyman Gary H.

Funder

Amgen, Inc

Publisher

Elsevier BV

Subject

Geriatrics and Gerontology,Oncology

Reference44 articles.

1. 2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours;Aapro;Eur J Cancer,2011

2. Risk and timing of neutropenic events in adult cancer patients receiving chemotherapy: the results of a prospective nationwide study of oncology practice;Crawford;J Natl Compr Canc Netw,2008

3. Epidemiology of febrile neutropenia;Lyman;Support Cancer Ther,2003

4. Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients;Kuderer;Cancer,2006

5. A retrospective study of the clinical and economic burden during hospitalizations among cancer patients with febrile neutropenia;Dulisse;J Med Econ,2013

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patterns of primary prophylactic granulocyte colony-stimulating factor use in older Medicare patients with cancer receiving myelosuppressive chemotherapy;Supportive Care in Cancer;2022-04-28

2. Management of elderly patients with malignant lymphoma;Japanese Journal of Clinical Oncology;2022-04-18